
Dubai - Sharikat Mubasher: Tarjama, a leading language solutions technology company based in the UAE, secured $15 million in a Series A funding round led by Global Ventures, with participation from Wamda Capital, TA Ventures, Phaze Capital, Golden Gate Ventures, and Endeavor Catalyst.
This investment will enable Tarjama to accelerate the rollout of its Arabic.AI agentic ecosystem, designed to help organizations solve complex business processes with AI agents tailored for the region’s unique needs, the company announced in a statement today.
Tarjama’s business model now serves rapidly growing demand for specialized Arabic AI from MENA’s 400 million Arabic speakers amid its fast-digitizing $3 trillion economy.
Commenting on this funding, Nour Al Hassan, Founder and CEO of Tarjama, said: "We’re delighted to close this Series A funding round and thank Global Ventures and all our other investors for their support and sharing our forward-looking vision. We have a vast market opportunity in our grasp; Arabic has been underserved by AI for too long. Our flagship product, Pronoia, changes that – it is far faster, more secure, and cost-effective.”
Pronoia combines high-performance language processing with enterprise-grade security and efficiency, making it the most accurate, cost-effective Arabic AI solution, outperforming GPT-4o, DeepSeek-V3, and Cohere on Arabic tasks.
Meanwhile, Said Murad, Senior Partner at Global Ventures, said: “Tarjama has multiple competitive advantages, both technically and culturally, and its state-of-the-art LLM, Pronoia, is purpose-built to dominate in a market where other AI tools have consistently fallen short. We are confident Tarjama’s profitable growth trajectory will continue, and its enterprise-grade Arabic AI solution will have global appeal.”
Tarjama’s growth strategy includes doubling Arabic.AI research and engineering teams, expanding its sovereign infrastructure, and launching an AI Academy to upskill hundreds of enterprise and government leaders in advanced AI deployment over the next 18 months.